We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research Discoveries and Treatment Approach of SARS-CoV-2 with Chinese Medicine and Acupuncture.
- Authors
Quesnel, V.; Asgarian, M.; Liu, D. Dong
- Abstract
COVID-19 is an infectious disease caused by the virus SARS-CoV-2, a coronavirus variant, which emerged on December 2019 in Wuhan, China. This paper presents an analysis and reflection of emerging research on the efficacy of Chinese medicine (CM) and acupuncture as a treatment for COVID-19. In CM, COVID-19 falls under the category of an epidemic disease. CM places COVID-19 into four stages: early, advanced, critical, and recovery. This research analysis presents the application of immunomodulatory acupuncture points and Chinese herbal prescriptions that may assist the body to defend against epidemic pathogens such as COVID-19 and future epidemic threats. Acupuncture has proven to be able to activate immune cells, at specific entry viral points, to prepare the body's immune system to fend off the viral invasion. The most common Chinese herbs to appear in research are Toujie Quwen granules, Lianhua Qingwen Capsules, Keguan-1, Xuebijing injection, and Chinese syndrome differentiation decoctions. The summary of evidence showed a benefit in the clinical cure, chest image improvement, and a reduction in clinical deterioration, acute respiratory distress syndrome, mechanical ventilation, and mortality with CM plus routine Western treatment compared to routine Western treatment alone. This critical analysis may prepare future generations for prevention, treatment, and integration of varying medical paradigms to effectively respond to a virus with global impact. Traditional Chinese medicine (TCM) is a viable adjunct in supportive care for patients with COVID-19.
- Publication
International Journal of Clinical Acupuncture, 2022, Vol 31, Issue 2, p138
- ISSN
1047-1979
- Publication type
Academic Journal
- DOI
10.3103/S1047197922020132